AAMI TIR80001 2 3 2012
$131.66
AAMI/IEC TIR80001-2-3:2012 – Application of risk management for IT-networks incorporating medical devices-Part 2-3: Guidance for wireless networks
Published By | Publication Date | Number of Pages |
AAMI | 2012 | 61 |
Supports the Healthcare Delivery Organizations (HDO) in the risk management of medical ITnetworks that incorporate one or more wireless links
PDF Catalog
PDF Pages | PDF Title |
---|---|
1 | ANSI/AAMI/IEC TIR80001-2-3:2012, Application of risk management for IT-networks incorporating medical devices — Part 2-3: Guidance for wireless networks |
3 | Title Page |
4 | Copyright |
5 | AAMI Technical Information Report ANSI Technical Report |
6 | Contents |
9 | Glossary of equivalent standards |
12 | Committee representation |
13 | Background of ANSI/AAMI adoption of IEC/TR 80001-2-3:2012 |
14 | FOREWORD |
16 | INTRODUCTION |
19 | 1 Scope and object 1.1 Scope 1.2 Objective |
20 | 1.3 HDO scalability 2 Normative references |
21 | 3 Terms and definitions |
31 | 4 Wireless medical IT-network: An introduction 4.1 Basics |
32 | 4.2 Enterprise medical IT-network 4.3 Use of VLANs and SSIDs |
33 | 4.4 Wide area medical IT-network |
34 | 4.5 Smart phone applications 4.5.1 General 4.5.2 Application clinical functionality 4.5.3 Cellular networks |
35 | 4.5.4 Smart phone coexistence 4.5.5 Wireless data security 4.6 Distributed antenna systems |
36 | 5 Wireless medical IT-networks: Planning and design 5.1 Clinical systems and their impact on the wireless network 5.1.1 Defining the clinical SLA 5.1.2 Creating partnerships 5.1.3 Geographical location |
37 | 5.1.4 Clinical use case 5.2 Medical device wireless capabilities 5.3 Medical device capabilities and networking traffic profile 5.4 Network performance requirements |
38 | 5.5 QoS mechanisms 5.6 Receiver capabilities |
39 | 5.7 Received signal strength and SNR versus data rates |
40 | 5.8 Capacity versus coverage versus AP density |
41 | 5.9 Deterministic versus non-deterministic wireless access protocol 5.10 Planning and design summary 6 Wireless medical IT-networks: Deployment and configuration 6.1 Risks versus benefit of a wireless communications system |
42 | 6.2 Licensed versus unlicensed spectrum 6.3 Interference sources 6.4 Spectrum usage and allocation 6.4.1 Device coexistence 6.4.2 Spectrum management |
43 | 6.4.3 Capacity management 6.5 Wireless network configuration (802.11 specific) 6.5.1 General 6.5.2 VLAN and SSID |
44 | 6.5.3 Authentication and encryption 6.5.4 Vendor proprietary extensions 6.5.5 Cellular and proprietary networks |
45 | 6.5.6 Network availability 6.6 Verification testing 6.6.1 General 6.6.2 Pre go-live verification testing 6.6.3 Go-live verification testing |
46 | 7 Wireless medical IT-networks: Management and support 7.1 General 7.2 Network and application management 7.3 Policies and procedures |
47 | 7.4 Change control 8 General risk control measures 8.1 General 8.2 Determining baseline networking performance |
48 | 8.3 Designing for coverage signal strength 8.4 Segregating traffic and data types 8.5 Environmental and physical changes 8.6 Maintaining a clean RF environment |
49 | 8.7 Capacity planning 8.7.1 General 8.7.2 5 GHz and dynamic frequency selection (DFS) 8.7.3 Security measures and planning |
50 | 8.8 RF spectrum use 8.9 Device and application classification |
51 | 8.10 Guest or smart phone access 8.11 WLAN infrastructure configuration 8.12 External partnering with both medical device and networking manufacturer 8.13 Redundancy |
53 | Annex A (informative) Clinical use cases and network traffic profiles |
55 | Annex B (informative) Questions to consider |
60 | Bibliography |